← All Jyong Biotech LTD filings

Jyong Biotech LTD F-1 registration statements

The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.

NASDAQ
MENS
Jyong Biotech LTD
F-1/A: Jyong Biotech Seeks Nasdaq Listing with Initial Public Offering
Jyong Biotech, a Taiwan-based biotechnology company, is planning an initial public offering of its ordinary shares, aiming for a Nasdaq listing under the symbol MENS.
NASDAQ
MENS
Jyong Biotech LTD
F-1/A: Jyong Biotech Ltd. Files Amendment for Proposed IPO on Nasdaq
Jyong Biotech Ltd. is moving forward with its IPO, aiming to list on the Nasdaq Global Market under the symbol 'MENS' after addressing FDA concerns regarding its lead drug candidate, MCS-2.